跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Beludan-2 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Beludan-2
Approved
STANDARD
Beludan-2
Hiral Labs Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c6e51a349f5d01a6
Company
Hiral Labs Limited
Type
Standard
Approval Details
Approval Id
c6e51a349f5d01a6
Drug Approval Philippines Name
Beludan-2
Product Name
Beludan-2
Registration Number
DRP-12911
Brand Name
Beludan-2
Generic Name
Ondansetron (as hydrochloride)
Dosage Form
Solution For Injection (IM/IV)
Dosage Strength
2 mg/mL
Manufacturer
Hiral Labs Limited
Importer
Bellus Life Solutions, Inc.
Distributor
Bellus Life Solutions, Inc.
Issuance Date
27 October 2022
Expiry Date
25 October 2027
Pharmacologic Category
Antiemetic (Serotonin (5-HT3) Antagonist)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c6e51a349f5d01a6
Type
Standard
Back to Philippines FDA Approvals